Get at-home solutions for all your health monitoring needs.

Product Platform

The medical device is designed for use by patients or caretakers in at-home setting. It has a similar form factor as a small glucose sensing device. It contains a reader and a single-use cartridge for each test. Each marker requires the use of a distinctive cartridge as each cartridge is specially designed for optimal performance. The time from test to results is in the range of 2-10 minutes, depending on the specific marker. Test results can be locally displayed and communicated to clinicians through cloud EHR connectivity.

*FemtoDx’s platform is in development and not available for patient use.

Product Platform Features

Patient Use

  • Designed for use by patients or caretakers in at-home setting with a device as small as a glucose sensor.

  • Perfect for at-home chronic conditions monitoring.

  • Time to result varies from 2 to 10 minutes, depending on the marker.

  • Results substantially equivalent to central lab instruments (such as Roche Cobas Analyzer).

Preventive Care

Continuous risk monitoring to

  • Determine the risk of a future event

  • Aid the care provider (hospital and clinicians) on actionable decisions

  • Monitor trend of marker value to assess disease status

  • Enable real-time alert through EHR connectivity for intervention if needed

System Components

Our Platform’s System includes the following components:

  • Reader (wireless charger included)

  • Cartridge

  • Lancet (third party)

  • Software/App and EMR Connectivity)  

Acute & Chronic Conditions Monitoring

  • Chronic conditions monitoring of diseases such as heart failure, rheumatoid arthritis & chronic kidney disease

  • Acute conditions monitoring of drug safety (such as drug induced liver injury) or adverse treatment response (such as Cytokine Release Syndrome (CRS) or Tumor Lysis Syndrome (TLS)

  • Non-invasive marker-based diagnosis

“I now appreciate how easy it would be monitoring my liver enzyme level from home on a regular basis, without having to make frequent visits to the hospital.”

— CHRISTINA., MULTIPLE SCLEROSIS PATIENT

Questions? Get in touch.